Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'DYSKINESIA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1673 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bezard, E; Brotchie, JM; Gross, CE
      Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies

      NATURE REVIEWS NEUROSCIENCE
    2. Hashimoto, T; Shindo, M; Yanagisawa, N
      Enhanced associated movements in the contralateral limbs elicited by briskvoluntary contraction in choreic disorders

      CLINICAL NEUROPHYSIOLOGY
    3. Haut, F; Clos, S
      Acute akathisia and sodium valproate

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    4. Procyshyn, RM; Flynn, S
      Discharge prescribing practices: Comparing a research ward to general treatment wards

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    5. Rybakowski, JK; Borkowska, A; Czerski, PM; Hauser, J
      Dopamine D3 receptor (DRD3) gene polymorphism is associated with the intensity of eye movement disturbances in schizophrenic patients and healthy subjects

      MOLECULAR PSYCHIATRY
    6. Govoni, S; Racchi, M; Masoero, E; Zamboni, M; Ferini-Strambi, L
      Extrapyramidal symptoms and antidepressant drugs: neuropharmacological aspects of a frequent interaction in the elderly

      MOLECULAR PSYCHIATRY
    7. Segman, RH; Heresco-Levy, U; Finkel, B; Goltser, T; Shalem, R; Schlafman, M; Dorevitch, A; Yakir, A; Greenberg, D; Lerner, A; Lerer, B
      Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia

      MOLECULAR PSYCHIATRY
    8. Basile, VS; Ozdemir, V; Masellis, M; Meltzer, HY; Lieberman, JA; Potkin, SG; Macciardi, FM; Petronis, A; Kennedy, JL
      Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia

      MOLECULAR PSYCHIATRY
    9. Lovlie, R; Thara, R; Padmavathi, R; Steen, VM; McCreadie, RG
      Ser9Gly dopamine D3 receptor polymorphism and spontaneous dyskinesia in never-medicated schizophrenic patients

      MOLECULAR PSYCHIATRY
    10. Herken, H; Uz, E; Ozyurt, H; Sogut, S; Virit, O; Akyol, O
      Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation ape increased in different forms of schizophrenia

      MOLECULAR PSYCHIATRY
    11. Purdon, SE; Woodward, ND; Flor-Henry, P
      Asymmetrical hand force persistence and neuroleptic treatment in schizophrenia

      JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
    12. Oosthuizen, P; Emsley, RA
      First-episode psychosis: lessons from 15 years of research

      PRIMARY CARE PSYCHIATRY
    13. Wooten, GF
      Anatomy and function of dopamine receptors: understanding the pathophysiology of fluctuations in Parkinson's disease

      PARKINSONISM & RELATED DISORDERS
    14. Nutt, JG
      Motor fluctuations and dyskinesia in Parkinson's disease

      PARKINSONISM & RELATED DISORDERS
    15. Hwang, WJ; Calne, DB; Tsui, JKC; de la Fuente-Fernandez, R
      The long-term response to levodopa in dopa-responsive dystonia

      PARKINSONISM & RELATED DISORDERS
    16. Krack, P; Vercueil, L
      Review of the functional surgical treatment of dystonia

      EUROPEAN JOURNAL OF NEUROLOGY
    17. Warren, BH; Crews, CK; Schulte, MM
      Managing patients with diabetes mellitus and mental health problems - Administrative and clinical challenges

      DISEASE MANAGEMENT & HEALTH OUTCOMES
    18. Desai, HD; Seabolt, J; Jann, MW
      Smoking in patients receiving psychotropic medications - A pharmacokineticperspective

      CNS DRUGS
    19. Yao, JK; Reddy, RD; van Kammen, DP
      Oxidative damage and schizophrenia - An overview of the evidence and its therapeutic implications

      CNS DRUGS
    20. Arranz, MJ; Mancama, D; Kerwin, RW
      Neurotransmitter receptor variants and their influence on antipsychotic treatment (Review)

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    21. Kennedy, A; Jain, S; Vinogradov, S
      Atypical antipsychotics for schizophrenia: Their collective role and comparative profiles

      FORMULARY
    22. Kharitonov, SA; Barnes, PJ
      Exhaled markers of pulmonary disease

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    23. Ho, JC; Chan, KN; Hu, WH; Lam, WK; Zheng, L; Tipoe, GL; Sun, J; Leung, R; Tsang, KW
      The effect of aging on nasal mucociliary clearance, beat frequency, and ultrastructure of respiratory cilia

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    24. Schneider, LS; Tariot, PN; Lyketsos, CG; Dagerman, KS; Davis, KL; Davis, S; Hsiao, JK; Jeste, DV; Katz, IR; Olin, JT; Pollock, BG; Rabins, PV; Rosenheck, RA; Small, GW; Lebowitz, B; Lieberman, JA
      National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) - Alzheimer disease trial methodology

      AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
    25. Madhusoodanan, S
      Introduction - Antipsychotic treatment of behavioral and psychological symptoms of dementia in geropsychiatric patients

      AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
    26. Farver, DK; Khan, MH
      Zolpidem for antipsychatic-induced parkinsonism

      ANNALS OF PHARMACOTHERAPY
    27. Kligman, MD; Madden, M; Arregui, ME
      Laparoscopic transcystic Sphincter of Oddi manometry is not affected by carbon dioxide pneumoperitoneum

      SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES
    28. Bryden, KE; Carrey, NJ; Kutcher, SP
      Update and recommendations for the use of antipsychotics in early-onset psychoses

      JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    29. Neesen, J; Kirschner, R; Ochs, M; Schmiedl, A; Habermann, B; Mueller, C; Holstein, AF; Nuesslein, T; Adham, I; Engel, W
      Disruption of an inner arm dynein heavy chain gene results in asthenozoospermia and reduced ciliary beat frequency

      HUMAN MOLECULAR GENETICS
    30. Naidu, PS; Kulkarni, SK
      Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): possible involvement of calcium and nitric oxide

      BEHAVIOURAL PHARMACOLOGY
    31. Collier, DA; Osborne, S; Munro, J; Kerwin, RW
      Pharmacogenetic methods in schizophrenia

      INTERNATIONAL REVIEW OF PSYCHIATRY
    32. Westin, JE; Andersson, M; Lundblad, M; Cenci, MA
      Persistent changes in striatal gene expression induced by long-term L-DOPAtreatment in a rat model of Parkinson's disease

      EUROPEAN JOURNAL OF NEUROSCIENCE
    33. Iravani, MM; Costa, S; Jackson, MJ; Tel, BC; Cannizzaro, C; Pearce, RKB; Jenner, P
      GDNF reverses priming for dyskinesia in MPTP-treated, L-DOPA-primed commonmarmosets

      EUROPEAN JOURNAL OF NEUROSCIENCE
    34. Bullock, R
      Drug treatment in dementia

      CURRENT OPINION IN PSYCHIATRY
    35. Malhotra, AK
      The genetics of schizophrenia

      CURRENT OPINION IN PSYCHIATRY
    36. Dutau, G; Micheau, P; Juchet, A; Rance, F; Bremont, F
      Chronic cough in children: etiologies and decision-making strategies.

      ARCHIVES DE PEDIATRIE
    37. Kane, JM
      Extrapyramidal side effects are unacceptable

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    38. Chengappa, KNR; Levine, J; Rathore, D; Parepally, H; Atzert, R
      Long-term effects of topiramate on bipolar mood instability, weight changeand glycemic control: a case-series

      EUROPEAN PSYCHIATRY
    39. Bergiannaki, JD; Hatzimanolis, J; Liappas, J; Sakkas, PN; Stefanis, CN
      Relapse prevention in schizophrenia: attitudes of neurologists-psychiatrists

      EUROPEAN PSYCHIATRY
    40. Schulze, TG; Muller, DJ; Krauss, H; Marwinski, K; Maroldt, AO; Fernandez, ANY; Fimmers, R; Held, T; Maier, W; Nothen, MM; Rietschel, M
      Affective symptomatology in schizophrenia: a risk factor for tardive dyskinesia?

      EUROPEAN PSYCHIATRY
    41. Salzman, C
      Treatment of the agitation of late-life psychosis and Alzheimer's disease

      EUROPEAN PSYCHIATRY
    42. McGlashan, TH
      Psychosis treatment prior to psychosis onset: ethical issues

      SCHIZOPHRENIA RESEARCH
    43. Peet, M; Brind, J; Ramchand, CN; Shah, S; Vankar, GK
      Two double-blind placebo-controlled pilot studies of eicosapentaenoic acidin the treatment of schizophrenia

      SCHIZOPHRENIA RESEARCH
    44. Quinn, J; Meagher, D; Murphy, P; Kinsella, A; Mullaney, J; Waddington, JL
      Vulnerability to involuntary movements over a lifetime trajectory of schizophrenia approaches 100%, in association with executive (frontal) dysfunction

      SCHIZOPHRENIA RESEARCH
    45. Dahmen, N; Muller, MJ; Germeyer, S; Rujescu, D; Anghelescu, I; Hiemke, C; Wetzel, H
      Genetic polymorphisms of the dopamine D-2 and D-3 receptor and neurolepticdrug effects in schizophrenic patients

      SCHIZOPHRENIA RESEARCH
    46. Salyers, MP; Mueser, KT
      Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia

      SCHIZOPHRENIA RESEARCH
    47. Srinivasan, TN; Thara, R; Padmavathi, R; McCreadie, RG
      Relationship of extrapyramidal symptoms to age at onset and drug treatmentin middle-aged and elderly schizophrenic patients

      SCHIZOPHRENIA RESEARCH
    48. Pifferi, M; Cangiotti, AM; Ragazzo, V; Baldini, G; Cinti, S; Boner, AL
      Primary ciliary dyskinesia: Diagnosis in children with inconclusive ultrastructural evaluation

      PEDIATRIC ALLERGY AND IMMUNOLOGY
    49. Biggart, E; Pritchard, K; Wilson, R; Bush, A
      Primary ciliary dyskinesia syndrome associated with abnormal ciliary orientation in infants

      EUROPEAN RESPIRATORY JOURNAL
    50. Bodfish, JW; Parker, DE; Lewis, MH; Sprague, RL; Newell, KM
      Stereotypy and motor control: Differences in the postural stability dynamics of persons with stereotyped and dyskinetic movement disorders

      AMERICAN JOURNAL ON MENTAL RETARDATION
    51. Lindamer, LA; Lohr, JB; Caligiuri, MP; Jeste, DV
      Relationship of gender and age at onset of schizophrenia to severity of dyskinesia

      JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
    52. Sullivan, EV; Fama, R; Shear, PK; Cahn-Weiner, DA; Stein, M; Zipursky, RB; Pfefferbaum, A
      Motor sequencing deficits in schizophrenia: A comparison with Parkinson's disease

      NEUROPSYCHOLOGY
    53. Kapur, RP
      Practicing pediatric pathology without a microscope

      MODERN PATHOLOGY
    54. Barbaccia, ML; Affricano, D; Purdy, RH; Maciocco, E; Spiga, F; Biggio, G
      Clozapine, but not haloperidol, increases brain concentrations of neuroactive steroids in the rat

      NEUROPSYCHOPHARMACOLOGY
    55. Scheepers, FE; de Wied, CCG; Pol, HEH; van de Flier, W; van der Linden, JA; Kahn, RS
      The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics

      NEUROPSYCHOPHARMACOLOGY
    56. Malone, RP; Cater, J; Sheikh, RM; Choudhury, MS; Delaney, MA
      Olanzapine versus haloperidol in children with autistic disorder: An open pilot study

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    57. Kafantaris, V; Coletti, DJ; Dicker, R; Padula, G; Kane, JM
      Adjunctive antipsychotic treatment of adolescents with bipolar psychosis

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    58. Pinna, A; Fenu, S; Morelli, M
      Motor stimulant effects of the adenosine A(2A) receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats

      SYNAPSE
    59. Sakai, K; Gao, XM; Hashimoto, T; Tamminga, CA
      Traditional and new antipsychotic drugs differentially alter neurotransmission markers in basal ganglia-thalamocortical neural pathways

      SYNAPSE
    60. Roberts, RC
      Effect of chronic olanzapine treatment on striatal synaptic organization

      SYNAPSE
    61. Grimm, JW; Chapman, MA; Zahm, DS; See, RE
      Decreased choline acetyltransferase immunoreactivity in discrete striatal subregions following chronic haloperidol in rats

      SYNAPSE
    62. Hansen, L
      A critical review of akathisia, and its possible association with suicidalbehaviour

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    63. Schultz, SK; Ellingrod, V; Fleming, FW; Andreasen, NC
      The association between risk factors for tardive dyskinesia and phenylalanine-induced abnormal movements in schizophrenia

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    64. Ahlskog, JE; Nishino, H; Evidente, VGH; Tulloch, JW; Forbes, GS; Caviness, JN; Gwinn-Hardy, KA
      Persistent chorea triggered by hyperglycemic crisis in diabetics

      MOVEMENT DISORDERS
    65. Maratos, EC; Jackson, MJ; Pearce, RKB; Jenner, P
      Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naive MPTP-lesioned common marmosets (Callithrix jacchus)

      MOVEMENT DISORDERS
    66. Fox, SH; Henry, B; Hill, MP; Peggs, D; Crossman, AR; Brotchie, JM
      Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: Evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan

      MOVEMENT DISORDERS
    67. Rascol, O; Arnulf, I; Paul, HPS; Brefel-Courbon, C; Vidailhet, M; Thalamas, C; Bonnet, AM; Descombes, S; Bejjani, B; Fabre, N; Montastruc, JL; Agid, Y
      Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease

      MOVEMENT DISORDERS
    68. Perniola, T; Margari, L; de Iaco, MG; Presicci, A; Ventura, P; Ferrannini, E; Illiceto, G
      Familial paroxysmal exercise-induced dyskinesia, epilepsy, and mental retardation in a family with autosomal dominant inheritance

      MOVEMENT DISORDERS
    69. Del Dotto, P; Pavese, N; Gambaccini, G; Bernardini, S; Metman, LV; Chase, TN; Bonuccelli, U
      Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study

      MOVEMENT DISORDERS
    70. Barlas, O; Hanagasi, HA; Imer, M; Sahin, HA; Sencer, S; Emre, M
      Do unilateral ablative lesions of the subthalamic nucleu in Parkinsonian patients lead to hemiballism?

      MOVEMENT DISORDERS
    71. Camicioli, R; Grossmann, SJ; Spencer, PS; Hudnell, K; Anger, WK
      Discriminating mild parkinsonism: Methods for epidemiological research

      MOVEMENT DISORDERS
    72. Shaffer, EA
      Acalculous biliary pain: Motility dysfunction and functional pain

      CANADIAN JOURNAL OF GASTROENTEROLOGY
    73. Riente, L; Fadda, P; Mazzantini, M; Frigelli, S; Fattori, B; Neri, E
      Kartagener's syndrome and rheumatoid arthritis: An unusual association

      CLINICAL RHEUMATOLOGY
    74. Nairn, SJ; Diaz, JE
      Cold-syrup induced movement disorder

      PEDIATRIC EMERGENCY CARE
    75. Tariot, PN; Ryan, JM; Porsteinsson, AP; Loy, R; Schneider, LS
      Pharmacologic therapy for behavioral symptoms of Alzheimer's disease

      CLINICS IN GERIATRIC MEDICINE
    76. Mahant, PR; Stacy, MA
      Movement disorders and normal aging

      NEUROLOGIC CLINICS
    77. Higgins, DS
      Chorea and its disorders

      NEUROLOGIC CLINICS
    78. Friedlander, R; Lazar, S; Klancnik, J
      Atypical antipsychotic use in treating adolescents and young adults with developmental disabilities

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    79. Ahmed, AG; Heigh, LM; Ramachandran, KV
      Polydipsia, psychosis, and familial psychopathology

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    80. Procyshyn, RM; Kennedy, NB; Tse, G; Thompson, B
      Antipsychotic polypharmacy: A survey of discharge prescriptions from a tertiary care psychiatric institution

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    81. Laugier, R; Grandval, P; Ville, E
      Dysfunction of the Oddi spincter

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    82. Fakhri, S; Manoukian, JJ; Souaid, JP
      Functional endoscopic sinus surgery in the paediatric population: Outcome of a conservative approach to postoperative care

      JOURNAL OF OTOLARYNGOLOGY
    83. Tammur, J; Prades, C; Arnould, I; Rzhetsky, A; Hutchinson, A; Adachi, M; Schuetz, JD; Swoboda, KJ; Ptacek, LJ; Rosier, M; Dean, M; Allikmets, R
      Two new genes from the human ATP-binding cassette transporter superfamily,ABCC11 and ABCC12, tandemly duplicated on chromosome 16q12

      GENE
    84. Rabasseda, X; Sorbera, LA; Martin, L; Leeson, PA; Castaner, J
      KW-6002 - Antiparkinsonian - Antidepressant - Adenosine A(2A) antagonist

      DRUGS OF THE FUTURE
    85. Rascol, O; Fabre, N
      Dyskinesia: L-dopa-induced and tardive dyskinesia

      CLINICAL NEUROPHARMACOLOGY
    86. Gimenez-Roldan, S; Esteban, EM; Mateo, D
      Switching from bromocriptine to ropinirole in patients with advanced Parkinson's disease: Open label pilot responses to three different dose-ratios

      CLINICAL NEUROPHARMACOLOGY
    87. Miyata, S; Hamamura, T; Yoshinaga, J; Nakamura, Y; Imamura, T; Hikiji, A; Kuroda, S
      Amelioration of frozen gait by tandospirone, a serotonin 1A agonist, in a patient with pure akinesia developing resistance to L-threo-3,4-dihydroxyphenylserine

      CLINICAL NEUROPHARMACOLOGY
    88. Djaldetti, R; Melamed, E
      New therapies for Parkinson's disease

      JOURNAL OF NEUROLOGY
    89. Kirton, CA; Riopelle, RJ
      Meige syndrome secondary to basal ganglia injury: A potential cause of acute respiratory distress

      CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
    90. Sutcher, H
      Prosthetic dentistry in the treatment of movement disorders: dyskinesias and other neurological abnormalities

      MEDICAL HYPOTHESES
    91. Liu, XG; Osterbauer, R; Aziz, TZ; Miall, RC; Stein, JF
      Increased response to visual feedback of drug-induced dyskinetic movementsin advanced Parkinson's disease

      NEUROSCIENCE LETTERS
    92. Bayas, A; Kornhuber, J; Naumann, M
      Atypical neuroleptics and new antidepressants in the treatment of neurological disorders

      AKTUELLE NEUROLOGIE
    93. Iwahashi, K; Anemo, K; Nakamura, K; Fukunishi, I; Igarashi, K
      Analysis of the metabolism of haloperidol and its neurotoxic pyridinium metabolite in patients with, drug-induced parkinsonism

      NEUROPSYCHOBIOLOGY
    94. Liao, DL; Yeh, YC; Chen, HM; Chen, H; Hong, CJ; Tsai, SJ
      Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients

      NEUROPSYCHOBIOLOGY
    95. Goasdoue, P; Rodriguez, D; Moutard, ML; Robain, O; Lalande, G; Adamsbaum, C
      Pontoneocerebellar hypoplasia: definition of MR features

      PEDIATRIC RADIOLOGY
    96. Zeng, BY; Pearce, RKB; MacKenzie, GM; Jenner, P
      Chronic high dose L-dopa treatment does not alter the levels of dopamine D-1, D-2 or D-3 receptor in the striatum of normal monkeys: an autoradiographic study

      JOURNAL OF NEURAL TRANSMISSION
    97. Berg, D; Becker, G; Naumann, M; Reiners, K
      Morphine in tardive and idiopathic dystonia

      JOURNAL OF NEURAL TRANSMISSION
    98. Garcia-Barcelo, MM; Lam, LCW; Ungvari, GS; Lam, VKL; Tang, WK
      Dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients

      JOURNAL OF NEURAL TRANSMISSION
    99. Bruns, HJ; Janssen, FW; Schafers, M; Hammel, D; Fetsch, T; Arslan, O; Krenz, M; Vahlhaus, C; Borggrefe, M; Scheld, HH; Schober, O; Breithardt, G; Wichter, T
      Signal characteristics of multichannel epicardial electrograms in chronic ischaemic and scarred myocardium: electromechanical mismatch indicates viability in regions of myocardial dysfunction

      BASIC RESEARCH IN CARDIOLOGY
    100. Fukasawa, T; Takahashi, M; Otani, K
      A successful clonazepam treatment without tolerance in a patient with spontaneous oral dyskinesia

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/02/20 alle ore 22:13:03